Goldman Sachs has advised Nordic Capital on the sale of Nycomed, a European pharmaceutical company, in one of the biggest secondary buy-outs this year.
CSFB Private Equity, Blackstone Capital Partners and NIB Capital Private Equity bought the Swedish private equity firm's majority shareholding for a reported figure of between €1.1bn ($1.1bn) and €1.2bn.